Skip to content

Machine Learning Combined with Proteomics for the Development of an Early Warning System for New-Onset Atrial Fibrillation in Sepsis

Machine Learning Combined with Proteomics for the Development of an Early Warning System for New-Onset Atrial Fibrillation in Sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117948
Enrollment
Unknown
Registered
2026-01-30
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

New-Onset Atrial Fibrillation (NOAF)

Interventions

Sepsis non-NOAF group:No
Sepsis NOAF group:NO

Sponsors

Fuzhou University Affiliated Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Met the Sepsis-3 diagnostic criteria (infection with Sequential Organ Failure Assessment [SOFA] score >=2); 2. New-onset atrial fibrillation occurring after ICU admission, confirmed by nursing records or electrocardiogram (ECG); 3. Aged 18–80 years; 4. Survived without self-discharge within 48 hours of ICU admission.

Exclusion criteria

Exclusion criteria: 1. History of paroxysmal or persistent atrial fibrillation prior to ICU admission; 2. Prior cardiac surgery (valve replacement, coronary artery bypass grafting), myocarditis, dilated cardiomyopathy, hypertrophic cardiomyopathy, rheumatic heart disease, or congenital heart disease; 3. Malignant tumor, organ transplant, or autoimmune disease; 4. Hyperthyroidism or pheochromocytoma; 5. Immunosuppressive therapy, hormone therapy, or immune checkpoint inhibitors within the preceding six months; 6. Pregnancy; 7. Human immunodeficiency virus (HIV) infection; 8. Chronic renal failure requiring hemodialysis or peritoneal dialysis; 9. Multiple ICU admissions (only the first ICU stay was retained.

Design outcomes

Primary

MeasureTime frame
Complete Blood Count;Liver and kidney function tests, Electrolytes ;NT-proBNP and troponin I;Procalcitonin (PCT), C-reactive protein, IL-6;Lipid profile;Incidence, recurrence, and cardioversion of atrial fibrillation;ICU mortality, in-hospital mortality, and mortality at 28, 60, 90, and 180 days;Lactate and blood gas Blood gas analysis;

Secondary

MeasureTime frame
Hospital LOS (Length of Stay), ICU LOS ;

Countries

China

Contacts

Public ContactCuilian Weng

Fuzhou University Affiliated Provincial Hospital

wengcuilian20051@sina.com+86 591 8861 8701

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026